Pdt Partners, LLC Cyma Bay Therapeutics, Inc. Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.72 - $3.39 $99,820 - $196,738	-58,035 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.23 - $4.6 $187,453 - $266,961	58,035 New	58,035 $196,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $153,558 - $241,994	-26,799 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.32 - $7.24 $88,972 - $194,024	26,799 New	26,799 $194,000
Q1 2020 May 15, 2020	SELL	$1.25 - $2.02 $17,750 - $28,684	-14,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.33 - $5.93 $18,886 - $84,206	14,200 New	14,200 $28,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.